Trial Profile
An Open Label, One Arm Pilot Study to Measure the Efficacy and Safety of Dysport in the Treatment of Vocal Tics in Patients With Tourette's Syndrome and Chronic Tic Disorders
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Gilles de la Tourette's syndrome; Tic disorders
- Focus Therapeutic Use
- 22 Jul 2014 New trial record